BridgeBio Pharma BBIO Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BridgeBio Pharma's investment proceeds?
- BridgeBio Pharma (BBIO) reported investment proceeds of $10M in Q1 2026.
- What does investment proceeds mean?
- Cash received from selling or maturing financial investments.
- How do you interpret investment proceeds?
- High inflows suggest the company is liquidating assets to support cash requirements or rebalancing its investment portfolio.
- How does investment proceeds compare across companies?
- Varies based on the company's cash management cycle and liquidity needs.